Unknown PHASE2 INTERVENTIONAL 1-arm NCT04062019

Low-dose Interleukin-2 Treatment on Idiopathic Inflammatory Myopathy

Sponsor: Peking University People's Hospital

Updated 5 times since 2019 Last updated: Aug 26, 2019 Started: Aug 30, 2019 Primary completion: Mar 31, 2021 Completion: Jun 30, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Inflammatory Myopathy, this trial is ongoing. The trial is conducted by Peking University People's Hospital and has accumulated 5 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Oct 2021 — Jul 2024 [monthly]

Unknown Status PHASE2

Status: Not Yet Recruiting → Unknown Status
Jan 2021 — Oct 2021 [monthly]

Not Yet Recruiting PHASE2
Sep 2019 — Jan 2021 [monthly]

Not Yet Recruiting PHASE2

First recorded

Aug 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Peking University People's Hospital

Data source: Peking University People's Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.